Owing to lower sale realisation in generics and higher tax adjustments in the US.
Dr. Reddy's Laboratories
Hyderabad: Dr. Reddy’s Laboratories on Thursday posted a 29 per cent drop in net profit in third quarter of fiscal 2018, owing to lower sale realisation in generics and higher tax adjustments in the US.
In Q3 FY18, the drug maker reported a profit Rs 334 crore compared to Rs 470 crore in the yearago period, a decline of 29 per cent.
( Source : Deccan Chronicle. )
Next Story